Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome
Clinical trial NCT00003681 · UNKNOWN
Trial details
- NCT number
- NCT00003681
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-08-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.